Sodium Reabsorption Mechanisms and the Pharmacology of Diuretics

Clinical Case Study: Mrs. Penelope Simmons

• Patient Profile: Mrs. Penelope Simmons is a patient being managed under the Department of Renal Medicine at City Hospitals Sunderland NHS Foundation Trust.
  • Patient Identification:
    • Date of Birth: $14/2/59$
    • Hospital Number (HN): $43669872$
    • Address: 3, Cock Law Road, Pallion, Sunderland, $SR4\,3NJ$
  • Clinical Communication: A clinic review letter from the Department of Renal Medicine (Sunderland District General Hospital) addressed to Dr. Jacjuck, prepared by secretary Ann Green (ext. $206$).
  • Problem List:
    • Type 1 Diabetes.
    • Secondary hypertension.
    • Stage G5, A3 Diabetic nephropathy (End-stage renal disease criteria).
  • Current Medication Regimen:
    • Darbepoetin: $60\,mcg$ once weekly via subcutaneous injection (for anemia management).
    • Aspirin: $75\,mg$ once daily ($od$).
    • Atorvastatin: $40\,mg$ once daily ($od$).
    • Calcitriol: $0.5\,Micrograms$ once daily ($od$).
    • Furosemide: $40\,mg$ once daily ($od$) (Note: Transcript mentions $0\,mg$ initially but implies a diuretic load; correcting to the standard context of Furosemide in the clinical narrative or noting the dosage provided as $40\,mg$ later in typical practice, though the transcript explicitly writes "Furosemide Omg od" which may indicate it was held or is a typo for $40$).
    • Amlodipine: $10\,mg$ once daily ($od$).
    • Lisinopril: $20\,mg$ once daily ($od$).
    • Insulins: Actrapid and Insulatard.
  • Recent Clinical Status:
    • Renal function is deteriorating significantly.
    • Estimated Glomerular Filtration Rate (eGFR): Fallen further to $14\,ml/min/1.73m^2$.
    • Serum Creatinine: Increased to $320\,μmol/L$ from $258\,μmol/L$ within the last $6$ months.
    • Symptoms: Anorexia, fatigue, reduced exercise tolerance, ankle oedema, and restless legs.
    • Haemoglobin (Hb): Dropped to $83\,g/L$, despite iron stores being adequate and an increase in Darbepoetin dosage.

Overview of Sodium ($Na^+$) Reabsorption Mechanisms in the Nephron

• Proximal Convoluted Tubule (PCT) and Loop of Henle Mechanisms:

  • Sodium/Glucose Transporter.
  • Sodium/Organic Solute Transporter.
  • Sodium/Phosphate Transporter.
  • Sodium/Hydrogen ($Na^+/H^+$) Exchanger.
  • Sodium/Bicarbonate ($Na^+/HCO_3^-$) Exchanger.
  • Paracellular reabsorption (between cells).
  • Sodium/Potassium/2-Chloride ($Na^+/K^+/2Cl^-$) Co-transporter (found in the Thick Ascending Loop of Henle).

• Basolateral Support: All active sodium transport is supported by the basolateral $Na^+/K^+$ ATPase Pump, which maintains the electrochemical gradient by moving $3$ $Na^+$ icons out of the cell for every $2$ $K^+$ ions moved in.

Sodium Reabsorption in the Early Distal Convoluted Tubule (DCT)

• Mechanism of Transfer:

  • Apical Membrane: Sodium and Chloride ($Cl^-$) enter the tubular cell via the $Na^+/Cl^-$ Cotransporter.
  • Basolateral Membrane: Sodium is pumped into the interstitium/peritubular capillary by the $Na^+/K^+$ ATPase pump ($3\,Na^+$ out, $2\,K^+$ in). Chloride moves out via chloride channels down its concentration gradient.
  • Permeability: This segment is water impermeable.
  • Gradients: Sodium enters the cell down its concentration gradient and is pumped against its concentration gradient on the basolateral side.

• Load Dependency:

  • Normally, approximately $5\%$ of filtered sodium is reabsorbed in the early DCT.
  • Reabsorption is "Load Dependent": If the sodium load is higher (e.g., more sodium passes unabsorbed through the Proximal Convoluted Tubule), the early DCT cotransporter can reabsorb more than the standard $5\%$. This is driven by a stronger gradient for the $Na^+/Cl^-$ cotransporter.

Sodium Reabsorption in the Late DCT and Collecting Duct

• Cell Type: Principal Cells perform the primary transport functions here.
• Mechanism:
  • Apical Membrane: Sodium enters via the ENaC (Epithelial Sodium Channel).
  • Basolateral Membrane: $Na^+/K^+$ ATPase pump maintains low intracellular sodium to facilitate entry.
  • Permeability: This segment is water impermeable unless regulated by other hormones (like ADH).
• Hormonal Regulation by Aldosterone:
  • Type: Aldosterone is a nuclear steroid hormone synthesized by the Zona Glomerulosa of the adrenal gland.
  • Action: It binds to receptors in Principal Cells to increase the expression of:
    1. Apical ENaC channels.
    2. $K^+$ channels (promoting secretion).
    3. Basolateral $Na^+/K^+$ ATPase pumps.
  • Result: Increased $Na^+$ reabsorption and increased $K^+$ excretion from the blood into the filtrate.

General Principles of Diuretics

• Definition: Drugs that decrease water reabsorption from the filtrate, typically by antagonizing the reabsorption of sodium ($Na^+$).
• The Golden Rule: Water typically follows sodium. Promoting sodium excretion (natriuresis) leads to increased water excretion (diuresis).
• Clinical Outcomes:
  • Increase in water and ion excretion.
  • Reduction in Extracellular Fluid (ECF) volume.
  • Reduction in Effective Circulating Volume (ECV).
  • Reduction in Blood Pressure.

Specific Classes of Diuretics

• Thiazide Diuretics:

  • Examples: Chlorthalidone and Indapamide.
  • Mechanism: Antagonizes the $Na^+/Cl^-$ Cotransporter in the Distal Convoluted Tubule.
  • Action: Blocks sodium reabsorption, increasing the hyperosmolarity of the filtrate, which causes more water to remain in the tubule for excretion.
  • Usage: Most commonly prescribed diuretic class.

• Loop Diuretics:

  • Examples: Furosemide and Bumetanide.
  • Mechanism: Antagonizes the $Na^+/K^+/2Cl^-$ Cotransporter in the Thick Ascending Loop of Henle.
  • Action: Promotes sodium excretion by blocking reabsorption. This increases the hyperosmolarity of the filtrate in the tubule, keeping water within the lumen to be excreted.

• Potassium-Sparing Diuretics:

  • These drugs are divided into two main classes based on their target:
  • Aldosterone Antagonists (e.g., Spironolactone):
    • Inhibits the expression of Apical ENaC, $K^+$ channels, and Basolateral $Na^+/K^+$ ATPase pumps.
    • Inhibits ENaC activators such as SGK1.
  • ENaC Antagonists (e.g., Amiloride):
    • Directly antagonizes ENaC channels in the Principal cells of the late DCT and Collecting Duct.

• Mechanisms of "Sparing" Potassium:

  • Reduced Intracellular Sodium: By blocking sodium entry, there is less intracellular sodium available for the $Na^+/K^+$ ATPase to exchange for potassium, reducing potassium translocation into the cell/filtrate.
  • Electrical Potential: These drugs decrease the net negative potential of the filtrate, which normally acts as a driving force for potassium secretion.
  • Transcription: Aldosterone antagonists specifically block the transcription of the pumps and channels required for potassium excretion.

• Osmotic Diuretics (Extra Information):

  • Example: Mannitol.
  • Mechanism: Freely filtered at the glomerulus but not reabsorbed.
  • Action: Increases the osmolality of the filtrate, which limits the reabsorption of water in the Proximal Convoluted Tubule (PCT) and the Descending Loop of Henle.
  • Result: Decreased ECF and blood pressure.